PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
34.15%
Revenue growth above 1.5x AVGO's 4.68%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
41.62%
Gross profit growth above 1.5x AVGO's 19.34%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
53.19%
EBIT growth above 1.5x AVGO's 14.44%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
53.19%
Operating income growth above 1.5x AVGO's 14.44%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
49.37%
Positive net income growth while AVGO is negative. John Neff might see a big relative performance advantage.
52.00%
Positive EPS growth while AVGO is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
48.00%
Positive diluted EPS growth while AVGO is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-0.20%
Share reduction while AVGO is at 0.28%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.20%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
-2.80%
Dividend reduction while AVGO stands at 0.09%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
15.50%
OCF growth above 1.5x AVGO's 8.36%. David Dodd would confirm a clear edge in underlying cash generation.
16.42%
FCF growth above 1.5x AVGO's 7.71%. David Dodd would verify if the firm’s strategic investments yield superior returns.
1518.55%
10Y revenue/share CAGR above 1.5x AVGO's 452.27%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
462.25%
5Y revenue/share CAGR above 1.5x AVGO's 102.31%. David Dodd would look for consistent product or market expansions fueling outperformance.
284.03%
3Y revenue/share CAGR above 1.5x AVGO's 70.41%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
4152.63%
10Y OCF/share CAGR above 1.5x AVGO's 747.40%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
1386.02%
5Y OCF/share CAGR above 1.5x AVGO's 75.12%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
474.19%
3Y OCF/share CAGR above 1.5x AVGO's 23.85%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
7228.78%
Positive 10Y CAGR while AVGO is negative. John Neff might see a substantial advantage in bottom-line trajectory.
641.72%
Positive 5Y CAGR while AVGO is negative. John Neff might view this as a strong mid-term relative advantage.
592.96%
Positive short-term CAGR while AVGO is negative. John Neff would see a clear advantage in near-term profit trajectory.
624.82%
10Y equity/share CAGR at 50-75% of AVGO's 1036.15%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
246.53%
5Y equity/share CAGR above 1.5x AVGO's 160.59%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
117.29%
3Y equity/share CAGR at 75-90% of AVGO's 138.07%. Bill Ackman pushes for margin or operational changes to match the competitor’s pace.
110.43%
Below 50% of AVGO's 1700.83%. Michael Burry might see weaker long-term distribution growth, raising questions about the firm's capital allocation.
5.21%
Below 50% of AVGO's 98.00%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
-1.86%
Negative near-term dividend growth while AVGO invests at 39.24%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
17.59%
Our AR growth while AVGO is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
10.65%
Inventory growth well above AVGO's 2.82%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
9.27%
Positive asset growth while AVGO is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
21.20%
Positive BV/share change while AVGO is negative. John Neff sees a clear edge over a competitor losing equity.
0.67%
We have some new debt while AVGO reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
12.45%
We increase R&D while AVGO cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
10.77%
We expand SG&A while AVGO cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.